Maven Securities LTD Protara Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$8.68 - $16.99 $1.49 Million - $2.93 Million
-172,177 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$13.75 - $23.86 $1.06 Million - $1.84 Million
77,177 Added 81.24%
172,177 $2.51 Million
Q4 2020

Feb 12, 2021
SELL
$16.97 - $25.34 $84,850 - $126,700
-5,000 Reduced 5.0%
95,000 $2.32 Million
Q3 2020

Nov 13, 2020
BUY
$16.76 - $31.89 $1.68 Million - $3.19 Million
100,000 New
100,000 $1.69 Million

Others Institutions Holding TARA

# of Institutions
39
Shares Held
10.7M
Call Options Held
9K
Put Options Held
1.8K
View Full List

About Protara Therapeutics, Inc.

TARA Quotes by TradingView
  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $60.7M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email